Study shows Hera Therapeutics compound combats HPV types that cause most cervical cancer
Research presented at the 29th Annual International Papillomavirus Conference shows that a therapy being developed by Hera Therapeutics Inc. combats three types of human papillomavirus, including the two that cause 70 percent ...
Aug 22, 2014
0
1